Michael T. Leininger

Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors

Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson et al. · Journal of Medicinal Chemistry · 2011 · 133 citations · Full text

Pharmaceutical Science, Clinical Candidate, Pharmacotherapy +16

Genetic Evidence of a Functional Monocyte Dichotomy

James L. Mobley, Michael T. Leininger, Steven J. Madore et al. · Inflammation · 2007 · 56 citations

Genetic Disorder, Cytogenetics, Genetics +2

P2Y1 receptor antagonists as novel antithrombotic agents

Jeffrey A. Pfefferkorn, Chulho Choi, Thomas Winters et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

Molecular Pharmacology, Platelet Aggregation Inhibitors, Thrombosis +8

Physiological response to acute endotoxemia in swine: effect of genotype on energy metabolites and leptin☆

Michael T. Leininger, Carla Portocarrero, A. P. Schinckel et al. · Domestic Animal Endocrinology · 2000 · 49 citations

Animal Physiology, Energy Metabolites, Energy Metabolism +11

C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclization

Ralph P. Robinson, Vincent Mascitti, Carine M. Boustany‐Kari et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 43 citations · Full text

C-5 Spirocyclization, Sugar Modifications, Medicinal Chemistry +12